#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelofibrosis Mantle cell lymphoma refractory Arginase deficiency Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Rhabdomyosarcoma recurrent Medullary thyroid cancer Synovitis Hairy cell leukaemia recurrent Congenital hypotransferrinaemia Urethral valves Erdheim-Chester disease Choroid melanoma Primitive neuroectodermal tumour Hyperadrenocorticism Red blood cell abnormality More trials…

    Learn about Rare Diseases

    Nephrotic syndrome – Trials in Disease Optic glioma – Life with Disease Primary mediastinal large B-cell lymphoma – Life with Disease Chordoma – Diagnostics Piriformis syndrome – Diagnostics Factor VIII deficiency Medulloblastoma recurrent – Life with Disease Glomerulonephritis membranoproliferative – Treatment Pleural mesothelioma malignant – Diagnostics Thrombotic thrombocytopenic purpura – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ibuprofen [89ZR]ZR-DFO-CIT-013 Zoledronic Acid Monohydrate GSKVX000000070965 Osimertinib Acoramidis Hydrochloride VANADIUM OXIDE SULFATE Idursulfase Emibetuzumab Azd5492 Ivonescimab Levosimendan Gad20-209-Fsp-A1 Clonidine Hydrochloride Methotrexate Lonvoguran Lib-01 Monohydrate Azd4831 Fosaprepitant Buloxibutid More therapies…

    Learn about Your Condition

    Glucose tolerance impaired Ischaemic skin ulcer Adrenal insufficiency Epstein-Barr virus infection Congenital ureteric anomaly Respiratory tract infection Infant sedation Oesophageal food impaction Basal cell naevus syndrome Periarthritis Sickle cell anaemia Hepatic angiosarcoma Hypoglycaemia Milk allergy Hip fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on 68Ga-FAPI-46 for Assessing Fibroblast Activation in Patients with Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Italy

  • Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Nemtabrutinib
    • Acalabrutinib
    • Ibrutinib
    Belgium Czechia Denmark Germany Greece Norway +4

  • Study on Stopping Esomeprazole in Patients with Liver Cirrhosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Placebo
    Germany

  • Study on Donepezil for Mild Cognitive Impairment in Parkinson’s Disease Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Donepezil Hydrochloride
    Spain

  • Study on Durvalumab with Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    • Non-small cell lung cancer stage IIIA
    • Non-small cell lung cancer stage IIIB
    Investigated Drugs:
    • Durvalumab
    The Netherlands

  • Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

    Recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • 12 Grass Pollen Mixture
    • Grass Pollen Allergen Extract Modified With Glutaraldehyde And Adsorbed To L-Tyrosine
    • Histamine Dihydrochloride
    Bulgaria Czechia Germany Lithuania Poland Romania +1
Previous Page
1 … 501 502 503 504 505 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!